- Home
- MRVI vs THRY Comparison
MRVI vs THRY Comparison
Compare MRVI & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- THRY
- Stock Information
- Founded
- MRVI 2020
- THRY 2003
- Country
- MRVI United States
- THRY United States
- Employees
- MRVI N/A
- THRY N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- THRY Industrial Machinery/Components
- Sector
- MRVI Health Care
- THRY Industrials
- Exchange
- MRVI Nasdaq
- THRY Nasdaq
- Market Cap
- MRVI 809.2M
- THRY 703.2M
- IPO Year
- MRVI 2020
- THRY 2020
- Fundamental
- Price
- MRVI $5.58
- THRY $15.30
- Analyst Decision
- MRVI Buy
- THRY Strong Buy
- Analyst Count
- MRVI 11
- THRY 3
- Target Price
- MRVI $10.03
- THRY $24.33
- AVG Volume (30 Days)
- MRVI 1.6M
- THRY 349.3K
- Earning Date
- MRVI 11-07-2024
- THRY 11-07-2024
- Dividend Yield
- MRVI N/A
- THRY N/A
- EPS Growth
- MRVI N/A
- THRY N/A
- EPS
- MRVI N/A
- THRY N/A
- Revenue
- MRVI $276,920,000.00
- THRY $873,723,000.00
- Revenue This Year
- MRVI N/A
- THRY N/A
- Revenue Next Year
- MRVI $3.41
- THRY N/A
- P/E Ratio
- MRVI N/A
- THRY N/A
- Revenue Growth
- MRVI N/A
- THRY N/A
- 52 Week Low
- MRVI $4.28
- THRY $13.06
- 52 Week High
- MRVI $11.56
- THRY $26.42
- Technical
- Relative Strength Index (RSI)
- MRVI 49.01
- THRY 43.67
- Support Level
- MRVI $5.45
- THRY $15.00
- Resistance Level
- MRVI $6.01
- THRY $16.66
- Average True Range (ATR)
- MRVI 0.34
- THRY 0.62
- MACD
- MRVI 0.12
- THRY -0.06
- Stochastic Oscillator
- MRVI 63.43
- THRY 4.35
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About THRY Thryv Holdings Inc.
Thryv Holdings Inc provides software as service (SaaS) management tools and digital and print marketing tools to small and mid-sized businesses. The company operates in four reportable segments namely Thryv U.S. Marketing Services, Thryv U.S. SaaS, Thryv International Marketing Services, and Thryv International SaaS. It generates maximum revenue from the Thryv U.S. Marketing Services segment.